Orbitazine
High Grade Gliomas
Shenzhen Zhenxing Medical Technology Co., LtdSmall moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the High Grade Gliomas cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Valproic Acid Virginia Commonwealth University | Phase 2 | BB |
Fluciclatide GE Healthcare | Phase 2 | CCC |
Tgx-007 Trogenix ltd | Phase 1/2 | CCC |
Oxodotreotide Fundación de investigación HM | Phase 1/2 | CCC |
F-18 RGD-K5 Siemens Molecular Imaging | Early Phase 1 | CC |
Same molecule, other indications
Orbitazine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →